Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - ALSERES PHARMACEUTICALS INC /DE | d614499dex311.htm |
| EX-31.2 - EX-31.2 - ALSERES PHARMACEUTICALS INC /DE | d614499dex312.htm |
| EX-32.1 - EX-32.1 - ALSERES PHARMACEUTICALS INC /DE | d614499dex321.htm |
| EXCEL - IDEA: XBRL DOCUMENT - ALSERES PHARMACEUTICALS INC /DE | Financial_Report.xls |
| 10-Q - 10-Q - ALSERES PHARMACEUTICALS INC /DE | d614499d10q.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Alseres Pharmaceuticals, Inc. (the “Company”) on Form 10-Q for the quarter ended March 31, 2013 as filed with the Securities and Exchange Commission (the “Report”), I, Kenneth L. Rice, Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| /S/ KENNETH L. RICE, JR. |
| Kenneth L. Rice, Jr. |
| Executive Vice President Finance and Administration and Chief Financial Officer |
Date: November 14, 2013